Hydrazine Sulfate Therapy (oral)
doctors orders - optional
Hydrazine sulfate (HS), a simple, mass-produced chemical compound, dramatically reverses cachexia, the wasting-away process that kills two-thirds of all cancer patients. This drug, with little or no side effects, also has a clinically documented anti tumor action. It causes malignant tumors to stop growing, to reduce in size and in some cases, to disappear. A growing number of cancer patients diagnosed as terminal have experienced tumor stabilization and remission through hydrazine sulfate therapy.
About half of all patients who take hydrazine sulfate experience weight gain, restored appetite, extended survival time, and a significant reduction in pain and suffering. Many patients report an increase in vigor and strength and the disappearance of symptoms of the disease, along with feelings of well-being and optimism.
In 1975 three articles would appear in the medical literature, detailing initial clinical results with hydrazine sulfate. The first, the Soviet study, 15 patients in a phase II controlled clinical trial, set forth astonishing results in a class of stage 4 patients termed “factually terminal” who had become unresponsive, or had failed to respond initially, to conventional therapy: 58 % demonstrated anti cachexia response (weight gain, performance status improvement, normalization of the laboratory indices, etc.), and 35 % showed anti tumor response (tumor regression or stabilization); one year later the initial series of 48 patients was enlarged to 95 patients, with essentially the same results.